@evolscientist

289 Followers
211 Following
60 Posts

Associate Professor. UNCC
. Evolution of genetic novelty.

You probably know me from Tw!tt3r. Still more active in The Bad Place.

Easy to find now on BlueSky.

The idea that antagonistic pleiotropy constrains evo between the sexes dates back to who? I've found papers referencing Darwin, Fisher, and then a bunch of refs in the 70s/80s.

Anyone in the know who can point me to a good review?

Note:Looking for phenotypes-not sex chrom evo.

Will see everyone at Evolution next week!
Ah, yes. Another day where my data is telling me that it just does not care what theory thinks. Time to dig in and see if it's real.

After an afternoon of hyperventilating over historic DNA preps, I think I have a plan that will lead to less hyperventilating tomorrow.

#RiskMgmt

Hell is troubleshooting randomly occuring segfaults in other people's code.
I recognize there are limits on funding and budgets. But the statement that trainees don't get to earn more than subsistence seems callous and tone-deaf. Even more so as many of us work towards better DEI within science.

A system designed to leave trainees without monetary resources before mid-30s/40s creates huge financial risks. Even more so with a tight faculty market.

https://www.investopedia.com/articles/personal-finance/040315/why-save-retirement-your-20s.asp

Why Save for Retirement in Your 20s?

You are probably paying off your student loans and retirement is 40 years away. Shouldn't you focus on eliminating debt and, maybe, saving for a home?

Investopedia

Note that this comes right on the heels of an RFI:

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-23-084.html

NOT-OD-23-084: Request for Information (RFI): Re-envisioning U.S. Postdoctoral Research Training and Career Progression within the Biomedical Research Enterprise

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Request for Information (RFI): Re-envisioning U.S. Postdoctoral Research Training and Career Progression within the Biomedical Research Enterprise NOT-OD-23-084. OD